Stay updated on Chemo +/- Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.

Latest updates to the Chemo +/- Nivolumab in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. No visible changes to the page content or study details.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now lists Revision: v3.4.2 as an addition and Revision: v3.4.1 as a deletion. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedPlatform revision updated from Revision: v3.4.0 to v3.4.1; no substantive changes to the study content, eligibility criteria, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a Show glossary option in the page header and updated the text labels for QC status, No FEAR Act data, and the revision footer (Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0). Removed the corresponding lowercase/older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4).SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. This is a minor metadata update that does not alter the study content or its presentation.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations are now presented under a single 'Locations' header listing Indiana, Minnesota, Texas, and Virginia, replacing the previous separate location headers; the page shows Revision: v3.3.3.SummaryDifference0.5%

Stay in the know with updates to Chemo +/- Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.